These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2203142)

  • 1. Bovine growth hormone: human food safety evaluation.
    Juskevich JC; Guyer CG
    Science; 1990 Aug; 249(4971):875-84. PubMed ID: 2203142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma GH, IGF-I, and conception rate in cattle treated with low doses of recombinant bovine GH.
    Bilby CR; Bader JF; Salfen BE; Youngquist RS; Murphy CN; Garverick HA; Crooker BA; Lucy MC
    Theriogenology; 1999 May; 51(7):1285-96. PubMed ID: 10729092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The somatotropic axis in neonatal calves can be modulated by nutrition, growth hormone, and Long-R3-IGF-I.
    Hammon H; Blum JW
    Am J Physiol; 1997 Jul; 273(1 Pt 1):E130-8. PubMed ID: 9252489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlabeled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication.
    Epstein SS
    Int J Health Serv; 1996; 26(1):173-85. PubMed ID: 8932606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and metabolic changes in neonatal calves in response to growth hormone and long-R3-insulin-like growth factor-I administration.
    Hammon H; Blum JW
    Biol Neonate; 1998; 73(2):121-8. PubMed ID: 9483305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of bovine growth hormone.
    Science; 1991 Jan; 251(4991):256-7. PubMed ID: 1987638
    [No Abstract]   [Full Text] [Related]  

  • 7. A model of consumers' risk perceptions toward recombinant bovine growth hormone (rbGH): the impact of risk characteristics.
    Grobe D; Douthitt R; Zepeda L
    Risk Anal; 1999 Aug; 19(4):661-73. PubMed ID: 10765429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of hepatic bovine growth hormone receptors in cattle.
    Badinga L; Collier RJ; Thatcher WW; Wilcox CJ; Head HH; Bazer FW
    J Anim Sci; 1991 May; 69(5):1925-34. PubMed ID: 2066302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and galactopoietic response to recombinant variants of bovine growth hormone.
    Eppard PJ; White TC; Birmingham BK; Hintz RL; Bentle LA; Wood DC; Salsgiver WJ; Rowold E; Miller MA; Ganguli S
    J Endocrinol; 1993 Dec; 139(3):441-50. PubMed ID: 8133211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bovine recombinant growth hormone administration on insulin-like growth factor-I and the haemopoietic system in thoroughbred geldings.
    Champion ZJ; James EA; Vickers MH; Breier BH; Casey PJ
    Vet J; 2000 Sep; 160(2):147-52. PubMed ID: 10985807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with bovine growth hormone is as effective as treatment during metabolic stress to reduce catabolism in fasted lambs.
    Ogawa E; Breier BH; Bauer MK; Gallaher BW; Grant PA; Walton PE; Owens JA; Gluckman PD
    Endocrinology; 1996 Apr; 137(4):1242-8. PubMed ID: 8625895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone treatment on the expression of somatotropic axis genes in the skeletal muscle of lactating Holstein cows.
    Castigliego L; Armani A; Grifoni G; Rosati R; Mazzi M; Gianfaldoni D; Guidi A
    Domest Anim Endocrinol; 2010 Jul; 39(1):40-53. PubMed ID: 20399067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a conventional immunoassay (ELISA) with a surface plasmon resonance-based biosensor for IGF-1 detection in cows' milk.
    Guidi A; Laricchia-Robbio L; Gianfaldoni D; Revoltella R; Del Bono G
    Biosens Bioelectron; 2001 Dec; 16(9-12):971-7. PubMed ID: 11679277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) therapy markedly increases the motility of spermatozoa and the concentration of insulin-like growth factor-I in seminal vesicle fluid in the male GH-deficient dwarf rat.
    Breier BH; Vickers MH; Gravance CG; Casey PJ
    Endocrinology; 1996 Sep; 137(9):4061-4. PubMed ID: 8756586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone concentration and disappearance rate, insulin-like growth factors I and II and insulin levels in iron-deficient veal calves.
    Ceppi A; Mullis PE; Eggenberger E; Blum JW
    Ann Nutr Metab; 1994; 38(5):281-6. PubMed ID: 7710263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native and recombinant bovine growth hormone antagonize insulin action in cultured bovine adipose tissue.
    Etherton TD; Evock CM; Kensinger RS
    Endocrinology; 1987 Aug; 121(2):699-703. PubMed ID: 3297651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant bovine growth hormone (rBGH) enhances somatic growth by regulating the GH-IGF axis in fingerlings of gilthead sea bream (Sparus aurata).
    Vélez EJ; Perelló M; Azizi S; Moya A; Lutfi E; Pérez-Sánchez J; Calduch-Giner JA; Navarro I; Blasco J; Fernández-Borràs J; Capilla E; Gutiérrez J
    Gen Comp Endocrinol; 2018 Feb; 257():192-202. PubMed ID: 28666853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal morphology in eight-day-old calves fed colostrum for different durations or only milk replacer and treated with long-R3-insulin-like growth factor I and growth hormone.
    Bühler C; Hammon H; Rossi GL; Blum JW
    J Anim Sci; 1998 Mar; 76(3):758-65. PubMed ID: 9535335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on human health concerns of recombinant bovine somatotropin use in dairy cows.
    Collier RJ; Bauman DE
    J Anim Sci; 2014 Apr; 92(4):1800-7. PubMed ID: 24663163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine placental lactogen is a potent somatogen in the growth hormone (GH)-deficient rat: comparison of somatogenic activity with bovine GH.
    Singh K; Ambler GR; Breier BH; Klempt M; Gluckman PD
    Endocrinology; 1992 May; 130(5):2758-66. PubMed ID: 1374015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.